Latest News of CVRX
CVRx Inc (CVRX) Q3 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses
By Yahoo! Finance |
3 weeks ago
CVRx narrowed its full-year guidance due to strong performance in October and Q3 momentum. The company aims for deeper market penetration and increased utilization. Successful reimbursement wins were ...
CVRx announces new CPT Category I codes for Barostim heart failure therapy
By Yahoo! Finance |
1 month ago
CVRx's Barostim therapy for heart failure symptoms receives new CPT Category I codes approved by AMA. This development will enhance reimbursement processes and expand patient access, with implementati...
CVRx touts positive two-year data for heart failure neuromodulation device
By Yahoo! Finance |
2 months ago
CVRx has reported positive long-term data on its Barostim device for heart failure patients over 24 months, showing improvements in various physical and psychosocial measures. The device received FDA ...
-
Insider Buying: CVRx President Bought US$251k Of Shares
By Yahoo! Finance | 3 months agoKevin Hykes, President of CVRx, recently bought $251k worth of stock at $8.36 per share, a positive sign for investors. Insiders have been buying shares in the last year, indicating optimism despite t...
-
Analysts Have Made A Financial Statement On CVRx, Inc.'s (NASDAQ:CVRX) Second-Quarter Report
By Yahoo! Finance | 3 months agoCVRx, Inc. (NASDAQ:CVRX) shares dropped 20% after its quarterly report, showing a loss of US$0.65 per share. Analysts forecast a revenue increase to US$50.4m in 2024, with losses rising to US$2....
-
While institutions own 41% of CVRx, Inc. (NASDAQ:CVRX), private equity firms are its largest shareholders with 44% ownership
By Yahoo! Finance | 3 months agoPrivate equity firms owning 44% of CVRx suggests more influence over management decisions. Institutions hold 41% while insiders own less than 1%. This shareholder distribution impacts governance and s...